Results from the first cohort of the AURORAX 087A study show the new biomarker-based test provides a more robust basis for making decisions on treatment than scans alone
A new, ultra-fast genetic test developed by NYU Langone Health may enable surgeons to identify cancer cells in real-time during brain surgery, improving tumor removal accuracy
How centralized informatics solutions can eliminate data silos, improve traceability, facilitate compliance, and reduce turnaround time
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.